Startup

Sun Bioscience

Description

Sun Bioscience, founded in 2016, is a pioneer in Precision Health, aiming to revolutionize personalized medicine by leveraging patient stem cells to identify effective drugs. Their proprietary Gri3D platform enables the automated, robust, and scalable generation of standardized organoids, including retinal, intestinal, cerebral, pancreatic, otic, and liver organoids. Academic collaborators and global corporations trust Sun Bioscience's technology to standardize their organoid cultures, facilitating drug development and advancing research in various fields.

About this result
This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.